Feedback
The current prices are delayed. Login to see live prices.
GlaxoSmithKline Pharmaceuticals Ltd.
(GLAXO)
20123456789,501234567890012345678980123456789.7012345678900123456789
-60.40 (-2.35%)
Updated 15:54 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹2,490.00
Today's high
₹2,590
52 week low
₹1,842.05
52 week high
₹3,088
Open
₹2,579
Prev Close
₹2,569.1
Volume (shares)
206,809
Total Trading Value
53.13 Cr
Technicals
SMA
Value
Signal
12-SMA
2,264.83
Bullish
20-SMA
2,151.63
Bullish
50-SMA
2,174.27
Bullish
100-SMA
2,361.83
Bullish
200-SMA
2,500.57
Bullish
Discussions
• Feb 20 3:31 AM
GLAXO Price action analysis
Based on the recent price action, GlaxoSmithKline Pharma...read more
4
1
• Feb 19 2:01 PM
• Feb 18 11:16 PM
GlaxoSmithKline Addresses Unexplained Stock Price Movement
• GlaxoSmithKline's stock experienced significant price changes on F...read more
• Feb 18 11:01 PM
Glaxo Reports Material Price Movement Without Explanation
• GlaxoSmithKline's share prices showed significant movement on Febr...read more
• Feb 18 5:52 PM
• Feb 18 12:40 AM
• Feb 17 8:49 PM
GlaxoSmithKline Announces Q3 Financial Results Publication
• GlaxoSmithKline has published its unaudited financial results for ...read more
• Feb 17 8:48 PM
GSK Analyst Meet Highlights Strong Q3 Performance and Growth Strategy
• Q3 FY2025 revenue increased by 18%, with growth across all busines...read more
• Feb 17 8:32 PM
GlaxoSmithKline Publishes Financial Results for Q3 FY 2024
• GlaxoSmithKline released unaudited financial results for Q3 and ni...read more
• Feb 17 8:32 PM
GlaxoSmithKline Q3 FY2025 Analyst Meeting Highlights Strong Growth and Future Plans...read more
• Feb 16 5:48 AM
Glaxosmithkline Phar - Quarterly Results
Earnings Update...read more
• Feb 15 5:01 PM
GlaxoSmithKline Reports on Analyst/Investor Meeting Outcomes
• The outcome of the analyst and institutional investor meetings was...read more
• Feb 14 11:18 PM
• Feb 14 10:01 PM
GlaxoSmithKline Releases Integrated Financial Results for Q3 FY2024
• The company's revenue from operations for Q3 FY2024 was 94,636 lak...read more
• Feb 14 9:47 PM
GSK Reports Strong Q3 Performance with 18% Revenue Increase
• GSK recorded an 18% increase in revenue for Q3 2024-25, amounting ...read more
• Feb 14 9:47 PM
GlaxoSmithKline Presents to Investors: Key Insights on Financial Growth and Strategy...read more
• Feb 14 9:31 PM
GlaxoSmithKline Pharmaceuticals Reports Q3 2024 Financial Results
• The company reported a revenue of Rs. 94,942 lakhs for the quarter...read more
• Feb 14 9:31 PM
GlaxoSmithKline Approves Financial Results and CFO Re-appointment
• The board approved the unaudited standalone and consolidated finan...read more
• Feb 14 9:16 PM
Glaxo Reports Strong Financial Results and Special Dividend
• GlaxoSmithKline Pharmaceuticals reported total income of Rs. 98,44...read more
• Feb 14 9:16 PM
GlaxoSmithKline Announces Strong Q3 Results and Key Executive Re-appointment
• The Board of Directors approved unaudited financial results for Q3...read more
• Feb 13 12:30 AM
• Feb 11 9:03 PM
GlaxoSmithKline Faces Rs. 2.19 Crore Tax Demand, No Immediate Financial Impact
• GlaxoSmithKline received a tax demand order totaling Rs. 2.19 cror...read more
• Feb 11 8:45 PM
GlaxoSmithKline Faces Tax Demand of Rs. 2.19 Crore
• GlaxoSmithKline has received a tax demand of Rs. 2.19 crore for th...read more
• Feb 11 5:46 PM
GlaxoSmithKline Schedules Analyst/Investor Meeting on February 14, 2025
• An analyst meeting is scheduled for February 14, 2025, to engage w...read more
• Feb 11 5:31 PM
GlaxoSmithKline Faces Rs. 2.19 Crore Tax Demand
• GlaxoSmithKline received a tax demand order totaling Rs. 2,19,72,0...read more
• Feb 11 5:31 PM
Glaxo Announces Analyst/Investor Meeting on February 14, 2025
• An analyst/investor meeting is scheduled for February 14, 2025, to...read more
• Feb 6 9:50 PM
• Feb 5 10:45 PM
Disclosure Under Regulation 30
As per attachment...read more
• Feb 4 6:00 PM
Disclosure Under Regulation 30
As per attachment...read more
• Feb 4 5:45 PM
Disclosure Under Regulation 30
As per attachment...read more
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of GlaxoSmithKline Pharmaceuticals Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of GlaxoSmithKline Pharmaceuticals Ltd. is Rs 2569.1 as of 21 February 2025.
What is the Market Capitalization of GlaxoSmithKline Pharmaceuticals Ltd. ?
The current market cap of GlaxoSmithKline Pharmaceuticals Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of GlaxoSmithKline Pharmaceuticals Ltd.?
GlaxoSmithKline Pharmaceuticals Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of GlaxoSmithKline Pharmaceuticals Ltd.?
The 52-week high of GlaxoSmithKline Pharmaceuticals Ltd. is Rs 3088 and the 52-week low is Rs 1842.05
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025